UBS AM’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$938 Buy
+30
New +$1.41K ﹤0.01% 4133
2025
Q3
– Sell
-4,170
Closed -$86.5K – 2414
2025
Q2
$86.5K Sell
4,170
-1,745
-30% -$38.4K ﹤0.01% 2591
2025
Q1
$102K Buy
+5,915
New +$145K ﹤0.01% 2599

Other funds holding GPCR

UBS AM's GPCR Position: Q3 2026 in Review

UBS AM opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 30 shares worth $938. The stake represents ﹤0.01% of the portfolio and ranks #4133 among its holdings. This is a return to the name: UBS AM previously reported a position in GPCR as recently as Q2 2025.

UBS AM first reported a position in GPCR in Q1 2025 and has held it in 3 quarters since. The position peaked at $102K in Q1 2025. 132 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • UBS AM held 30 shares of Structure Therapeutics worth $938 as of Q3 2026.
  • Structure Therapeutics was a new UBS AM position in Q3 2026.
  • Structure Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4133 holding.
  • UBS AM first reported a position in Structure Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • UBS AM's Structure Therapeutics position peaked at $102K in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.